Alibaba and Sunshine Insurance Group have contributed to a series F round for Souche, which also revealed its acquisition of Iyunche and Breakthrough.

Biomolecule classification technology developer Arago Bioscience emerged out of Oxford in April this year and has now been backed by two of the university's funds.

Oxford Sciences Innovation has contributed to a series B round for Evox Therapeutics, a spinout of University of Oxford that has also added GV as a shareholder.

Eight researchers from Cambridge have raised a $129m patient capital fund that has attracted limited partners including Aviva.

Legal & General has co-led a $20m series B round for Salary Finance, a financial wellbeing platform for employees.

Daun Penh Cambodia Group and Sistema Asia Fund were among the investors in a $35m series C round for online pharmacy NetMeds.

GV has contributed to a series B round for Evox Therapeutics, a spinout of University of Oxford whose existing shareholders include Oxford Sciences Innovation.

Eight researchers from Cambridge have raised a $129m patient capital fund that has attracted limited partners including Aviva.